View Post

Researchers discover coffee drinkers could halve their risk of liver cancer

In In The News by Barbara Jacoby

From: Queen’s University Belfast A research team from Queen’s University Belfast has found that coffee drinkers have a lower risk of the most common type of liver cancer, hepatocellular carcinoma (HCC). The results have been presented at the National Cancer Research Institute (NCRI) conference in Glasgow this week and was published in British Journal of Cancer earlier this year. Coffee is one …

View Post

Scientists crack structure of a novel enzyme linked to cell growth and cancer

In In The News by Barbara Jacoby

By: Iqbal Pittalwala From: University of California Riverside RNA, or ribonucleic acid, is present in the cells of all living beings and required to synthesize proteins. A research team at the University of California, Riverside, has discovered the structure of a novel RNA-modifying enzyme, ZCCHC4, and identified the mechanism that controls how this enzyme recognizes its substrate. ZCCHC4 influences cell …

View Post

3D Mammograms: Are They Worth It?

In In The News by Barbara Jacoby

From: cedars-sinai.org Cedars-Sinai Breast Radiologist Explains the Procedure, Who Should Get It and Why If it’s October, it’s Breast Cancer Awareness Month, when pink ribbons sprout up on everything from suit lapels to yogurt containers, reminding women to turn their attention to breast health—especially mammograms. As 3D mammography, also called digital breast tomosynthesis, has become more available nationwide, a big …

View Post

Hormone Therapy for Breast Cancer

In In The News by Barbara Jacoby

By: Elaine K. Howley From: usnews.com This article is based on reporting that features expert sources including Margaret Chen, MD, FACS; Hannah M. Linden, MD There are a variety of ways cancer cells can grow, and for some kinds of breast cancer, hormones feed these wayward cells. Combating the effects of hormones on cancer cells can help slow or stop …

View Post

FDA’s New Policy to Increase Use of 3-D Digital Breast Screening Tools Will Be Market Driver for Breast CT

In In The News by Barbara Jacoby

From: media@thenewswire.com There is mounting evidence from many sources about mammography being an inferior method for identifying or helping in the diagnosis of suspicious breast lesions that may be cancer. ­  Some informed sources say mammography is completely unnecessary, and others go as far to say that mammography causes more harm than good.  Regardless, mammography is the current gold standard …

View Post

Stage 4 Breast Cancer Recurrence and Remission

In In The News by Barbara Jacoby

From: healthline.com Understanding Stage 4 cancer Breast cancer is categorized by stages that describe the nature of the disease and the person’s outlook. Stage 4, or metastatic, breast cancer means the cancer has spread — or metastasized — beyond its point of origin to other organs and tissues. For women who received a diagnosis between 2009 and 2015, the 5-year …

View Post

SD Mines Researchers Target, Kill Cancer Cells with Cold Plasma

In In The News by Barbara Jacoby

Source: South Dakota School of Mines & Technology, While using cold plasma to kill cancer cells isn’t an entirely novel concept, a team of researchers and students at South Dakota School of Mines & Technology are exploring new ways to regulate cold plasma technology to target and kill cancer cells while leaving healthy cells alive. If successful, the technique would …

View Post

Hope for cancer patients, as the development of immuno-oncology therapies continues to grow globally

In In The News by Barbara Jacoby

Source: GlobalData From: prnewswire.com The number of immuno-oncology (IO) therapies in clinical development and volume of clinical investigations testing these therapies for the treatment of cancer patients continue to grow, and will undoubtedly fulfill unmet needs in both hematological cancers and solid tumors over the next five to ten years. Leveraging data from GlobalData’s Pharma Intelligence platform, an Immuno-oncology Landscape update from the …

View Post

Generic Fulvestrant Injection Launched for Breast Cancer Monotherapy in Post-Menopausal Women

In In The News by Barbara Jacoby

From: pharmacytimes.com Amneal has announced the launch of fulvestrant injection, an AO-rated generic equivalent for the reference product fulvestrant (Faslodex, AstraZeneca) injection, in a dosage strength of 250 mg/5 ml (50 mg/ml) per single-dose prefilled syringe. Fulvestrant injection is used as a monotherapy to treat certain types of breast cancer in post-menopausal women who were not previously treated with endocrine …

View Post

Patient-Reported Outcomes Bolster Breast Cancer Treatment

In In The News by Barbara Jacoby

By: Seth Augenstein From: cancernetwork.com Patients, providers, and healthcare processes benefit from systematically collecting patient-reported outcomes and reviews of their experiences in breast cancer treatment, according to a new study by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The findings show that patient-reported outcome measures (PROMs) could be of most benefit if standardized across healthcare, despite the difficulties …